Publications by authors named "Gabriella Alonzi"
Article Synopsis
- * Researchers evaluated 80 patients in remission for at least six months using various clinical measures and performed ultrasound assessments on multiple joints and tendons to gauge synovitis and tenosynovitis.
- * Results showed that while clinical remission rates were higher in drug-free patients, ultrasonographic remission was more commonly observed among patients who were receiving treatment.
Objectives: to report real-life data on rituximab retention-rate as indicator of safety and efficacy in a multicentric national cohort of systemic sclerosis patients.
Methods: SSc patients treated with rituximab and followed for at least 36 months were included, clinically characterized, and longitudinally monitored. A competing risk analysis with sub-Hazard Ratio(sHR) definition was performed to explore the clinical variables linked to specific cause of rituximab discontinuation.